Single-center Clinical Trial Evaluating the Efficacy, Safety, Feasibility, Reliability, and Cost-effectiveness of In-ambulance Telemedicine for Patients With Suspicion of Acute Stroke
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- Universitair Ziekenhuis Brussel
- Enrollment
- 140
- Locations
- 1
- Primary Endpoint
- Call-to-brain imaging time
- Last Updated
- 10 years ago
Overview
Brief Summary
Interventional prospective randomized open blinded end-point (PROBE) single-center clinical trial on the evaluation of the efficacy, safety, feasibility, reliability, and cost-effectiveness of in-ambulance telemedicine for patients with suspicion of acute stroke.
Detailed Description
The purpose of PreSSUB II is to evaluate the efficacy, safety, feasibility, reliability and cost-effectiveness of in-ambulance telemedicine during Paramedic Intervention Team transportation of patients with suspicion of acute stroke. The implementation of expert stroke support in the pre-hospital arena using in-ambulance telemedicine is an innovative approach that opens up new perspectives and allows continuous guidance by a stroke specialist throughout the acute stroke care continuum.
Investigators
Raf Brouns, MD, PhD
MD PhD
Universitair Ziekenhuis Brussel
Eligibility Criteria
Inclusion Criteria
- •Emergency transportation by the Paramedic Intervention Team of the Universitair Ziekenhuis Brussel
- •Age \>= 18 years
- •Suspicion of acute stroke with symptom onset \< 12 h or unknown, based on any of the symptoms mentioned in the Belgian manual for medical regulation of pre-hospital care: Hemiparesis, Facial asymmetry, Speech disturbance, Sudden, severe headache, or Confusion.
Exclusion Criteria
- •Patients for whom in-ambulance telemedicine consultation would delay any diagnostic or therapeutic intervention.
Outcomes
Primary Outcomes
Call-to-brain imaging time
Time Frame: within 2 hours
Interval between emergency call and imaging of the brain by computed tomography or magnetic resonance imaging in the hospital.
Secondary Outcomes
- Medical events during in-ambulance telemedicine(within 2 hours)
- Clinical outcome(upto 12 months)
- Recanalisation therapy(upto 8 hours)